Building on the legacy of Nico van Rooijen’s clodronate liposomes, Liposoma has evolved into a cutting-edge biotechnology company specializing in liposomal delivery systems. Liposomes—tiny, spherical vesicles made of phospholipid bilayers—serve as biocompatible carriers that can encapsulate both water-soluble and fat-soluble compounds. Their unique structure mimics cell membranes, making them ideal for safe and targeted delivery.

Liposoma utilizes this versatile platform to develop and manufacture liposome-encapsulated formulations for diverse sectors, including:

1. Immunological Research

• Clodronate liposomes, developed by Van Rooijen, remain a cornerstone product.
• These liposomes are used in research to temporarily deplete macrophages, helping scientists understand immune responses and disease mechanisms.

2. Medical Nutrition & Dietary Supplements

• Liposoma creates liposomal formulations of vitamins and minerals.
• Encapsulation enhances bioavailability, absorption, and stability, often outperforming traditional supplements.
• These formulations are especially valuable in clinical settings or for individuals with absorption challenges.

3. Pharmaceutical Development

• Liposomes enable targeted drug delivery, reducing side effects and improving therapeutic outcomes.
• Liposoma develops customized liposomal carriers for preclinical and clinical use, including for oncology, inflammatory diseases, and infectious diseases.
• Their liposomes can be engineered for specific release profiles, tissue targeting, or immune evasion.
  
  

4. Cosmetics and Dermatology

• Liposomal encapsulation of active ingredients like hyaluronic acid, coenzyme Q10, or niacinamide improves skin penetration, efficacy, and moisture retention.
• Liposoma develops formulations for brands aiming to deliver scientifically substantiated cosmetic benefits.